DK1276722T3 - Naphthamidin-urokinaseinhibitorer - Google Patents
Naphthamidin-urokinaseinhibitorerInfo
- Publication number
- DK1276722T3 DK1276722T3 DK01934906T DK01934906T DK1276722T3 DK 1276722 T3 DK1276722 T3 DK 1276722T3 DK 01934906 T DK01934906 T DK 01934906T DK 01934906 T DK01934906 T DK 01934906T DK 1276722 T3 DK1276722 T3 DK 1276722T3
- Authority
- DK
- Denmark
- Prior art keywords
- urokinase
- naphthamidin
- inhibitors
- urokinase inhibitors
- inhibiting
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US55751700A | 2000-04-25 | 2000-04-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1276722T3 true DK1276722T3 (da) | 2006-07-17 |
Family
ID=24225737
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK01934906T DK1276722T3 (da) | 2000-04-25 | 2001-04-25 | Naphthamidin-urokinaseinhibitorer |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1276722B1 (da) |
JP (1) | JP4881532B2 (da) |
AT (1) | ATE319689T1 (da) |
CA (1) | CA2407043C (da) |
DE (1) | DE60117783T2 (da) |
DK (1) | DK1276722T3 (da) |
ES (1) | ES2260222T3 (da) |
MX (1) | MXPA02010593A (da) |
PT (1) | PT1276722E (da) |
WO (1) | WO2001081314A1 (da) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE50310038D1 (de) | 2002-03-11 | 2008-08-07 | Curacyte Ag | Hemmstoffe der urokinase, ihre herstellung und verwendung |
DE10301300B4 (de) | 2003-01-15 | 2009-07-16 | Curacyte Chemistry Gmbh | Verwendung von acylierten 4-Amidino- und 4-Guanidinobenzylaminen zur Inhibierung von Plasmakallikrein |
DE10342108A1 (de) | 2003-09-11 | 2005-04-14 | Curacyte Chemistry Gmbh | Basisch-substituierte Benzylaminanaloga als Inhibitoren des Gerinnungsfaktors Xa, ihre Herstellung und Verwendung |
GB0507577D0 (en) | 2005-04-14 | 2005-05-18 | Novartis Ag | Organic compounds |
DE102006050672A1 (de) | 2006-10-24 | 2008-04-30 | Curacyte Discovery Gmbh | Hemmstoffe des Plasmins und des Plasmakallikreins |
DE102008026208A1 (de) | 2008-05-30 | 2009-12-03 | Süd-Chemie AG | Verfahren zur Herstellung kupfer- und chromhaltiger Mischoxide |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA928276B (en) * | 1991-10-31 | 1993-05-06 | Daiichi Seiyaku Co | Aromatic amidine derivates and salts thereof. |
ZA986594B (en) * | 1997-07-25 | 1999-01-27 | Abbott Lab | Urokinase inhibitors |
-
2001
- 2001-04-25 CA CA2407043A patent/CA2407043C/en not_active Expired - Fee Related
- 2001-04-25 EP EP01934906A patent/EP1276722B1/en not_active Expired - Lifetime
- 2001-04-25 PT PT01934906T patent/PT1276722E/pt unknown
- 2001-04-25 DE DE60117783T patent/DE60117783T2/de not_active Expired - Lifetime
- 2001-04-25 MX MXPA02010593A patent/MXPA02010593A/es active IP Right Grant
- 2001-04-25 AT AT01934906T patent/ATE319689T1/de active
- 2001-04-25 DK DK01934906T patent/DK1276722T3/da active
- 2001-04-25 WO PCT/US2001/013491 patent/WO2001081314A1/en active IP Right Grant
- 2001-04-25 JP JP2001578408A patent/JP4881532B2/ja not_active Expired - Fee Related
- 2001-04-25 ES ES01934906T patent/ES2260222T3/es not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
PT1276722E (pt) | 2006-07-31 |
EP1276722B1 (en) | 2006-03-08 |
CA2407043C (en) | 2010-02-16 |
ATE319689T1 (de) | 2006-03-15 |
MXPA02010593A (es) | 2003-05-14 |
EP1276722A1 (en) | 2003-01-22 |
JP4881532B2 (ja) | 2012-02-22 |
WO2001081314A1 (en) | 2001-11-01 |
CA2407043A1 (en) | 2001-11-01 |
DE60117783D1 (de) | 2006-05-04 |
JP2003531837A (ja) | 2003-10-28 |
ES2260222T3 (es) | 2006-11-01 |
DE60117783T2 (de) | 2006-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1248612A4 (en) | NEW SUBSTANCES AND COMPOUNDS AS PROTEASE INHIBITORS | |
AP1699A (en) | New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors | |
PL406680A1 (pl) | Inhibitory kinaz tyrozynowych | |
MXPA03011681A (es) | Uso de inhibidores de epoxido hidrolasa soluble, para tratar enfermedades relacionadas con la enfermedad cardiovascular. | |
MXPA02005844A (es) | Inhibidores de cinasas de proteina. | |
NO20025601L (no) | Arylmetylaminderivater for anvendelse som tryptaseinhibitorer | |
IS6655A (is) | Sýklópentanóindól, efnablöndur sem innihalda slíkefnasambönd og meðhöndlunaraðferðir | |
WO1999005096A3 (en) | Urokinase inhibitors | |
YU84603A (sh) | Novi inhibitori tirozin kinaze | |
DK1509232T3 (da) | Kombination af en NMDA-antagonist og acetylcholin-esterase inhibitorer til behandling af Alzheimers sygdom | |
IS6069A (is) | N-cýanómetýlamíð sem próteasalatar | |
MY138797A (en) | Bacterial gyrase inhibitors and uses thereof | |
PL361404A1 (en) | Synergistic combinations comprising a renin inhibitor for cardiovascular diseases | |
GB0112348D0 (en) | Compounds | |
EA200001129A2 (ru) | Способ получения 4-карбоксиамино-2-замещенного-1,2,3,4-тетрагидрохинолина | |
WO2003106450A8 (de) | Phenylaminopyrimidine und ihre verwendung als rho-kinase inhibitoren | |
MXPA03005601A (es) | Nuevos compuestos y composiciones como inhibidores de catepsina. | |
EA200301203A1 (ru) | Новые соединения и композиции как ингибиторы катепсина | |
WO2001081316A3 (en) | Substituted phenyl farnesyltransferase inhibitors | |
ATE443044T1 (de) | Tace inhibitoren | |
SE0003476D0 (sv) | Compounds | |
WO2004032908A3 (en) | Method of inhibiting angiogenesis | |
MXPA04005809A (es) | Inhibidores de proteinas quinasas. | |
MXPA03001356A (es) | Nuevos agentes inhibidores de beta-amiloides, procedimientos para su preparacion y su uso como medicamentos. | |
ATE419242T1 (de) | Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren |